XML 16 R6.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Dec. 31, 2021
Cash Flows From Operating Activities          
Net loss     $ (10,997,463) $ (10,401,863)  
Adjustments to reconcile net loss to net cash used in operating activities:          
Depreciation and amortization expense     2,881,967 1,678,067  
Bad debt expense     479,065 79,305  
Gain on debt extinguishment $ 0 $ 0 (1,205,195) (24,925)  
Equity based compensation expense     3,415,670 3,543,887  
Warrant modification expense     152,244 12,624  
Recognized loss on marketable securities     0 1,424  
Loan principal paid directly through grant     0 (2,992)  
Amortization of debt discount and debt costs     135,161 2,503,160  
Impairment expense     2,129,101 2,530,325  
Initial derivative expense     0 3,585,983  
Change in fair value of derivative liability     0 (7,315,580)  
Factoring discount fee and interest     150,117 0  
Change in fair value of earn-out liability     26,604 102,116 $ 35,294
Changes in assets and liabilities:          
Increase in accounts receivable     (1,273,012) (3,517,385)  
Increase in accounts receivable - related parties     49,033 15,043  
Increase in prepaid expenses and other current assets     (64,221) (53,823)  
Increase in accounts payable and accrued liabilities     (146,406) 642,427  
Decrease in accounts payable and accrued liabilities - related parties     (163,672) (687,460)  
Deferred payroll taxes     0 (135,699)  
Increase in other liabilities     0 2,840  
(Decrease) increase in deferred revenue     (226,208) 456,824  
Net cash used in operating activities     (4,657,214) (6,985,702)  
Cash Flows From Investing Activities:          
Cash and receivables aquired     0 230,855  
Capitalized software development costs     (1,325,491) 0  
Cash paid for acquisitions; net of cash acquired     0 (2,304,528)  
Purchase of property and equipment     (73,037) 0  
Net cash used in investing activities     (1,398,528) (2,073,673)  
Cash Flows From Financing Activities:          
Proceeds from notes     2,135,000 250,000  
Proceeds from convertible notes     0 2,153,200  
Deferred offering costs   (78,038) 0 (78,038)  
Payments of loans     (1,323,773) (156,131)  
Repayments of sale of future revenues       (10,904)  
Procceds from factoring agreement     5,613,871 0  
Repayments of factoring agreement     (2,944,876) 0  
Offering Costs     0 (1,651,889)  
Proceeds from sale of common stock and warrants     0 13,800,000  
Net cash provided by financing activities     3,480,222 14,306,238  
Net increase (decrease) in cash     (2,575,520) 5,246,863  
Cash, beginning of period     2,584,062 99,906 99,906
Cash, end of period $ 8,542 $ 5,346,769 8,542 5,346,769 $ 2,584,062
Supplemental disclosures of cash flow information:          
Cash paid during the period for interest     208,351 175,580  
Cash paid during the period for income taxes     0 0  
Supplemental schedule of non-cash investing and financing activities:          
Accounts receivable owed under factoring agreement collected directly by factor     1,955,289 0  
Purchase price measurement period adjustment to goodwill and accounts receivable     35,644 0  
Original issue discount deducted from convertible note proceeds     0 342,554  
Debt discount on warrants granted with notes     1,032,842 0  
Debt costs deducted from convertible note proceeds     0 334,800  
Loans issued as consideration for acquisitions     0 4,750,000  
Notes and accrued interest converted to common stock     0 4,647,794  
Common stock issued/to be issued for asset acquisitions     0 8,241,082  
Notes payable and accrued interest exchanged for debentures     0 252,430  
Accounts payable paid with common stock     0 140,000  
Accrued compensation paid with common stock     0 16,425  
Warrant derivative liability extinguished     0 10,182,476  
Write off of right-of-use asset and lease liability     0 103,953  
Earn-out liability consideration for acquisition     0 1,668,297  
Shares issued for Upsider earn-out liability     0 1,394,768  
Deferred offering costs charged to additional paid-in capital     $ 0 $ 78,038